NCT02695381View on ClinicalTrials.gov

Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Acute Delayed Onset Muscle Soreness (DOMS)
Interventions
DRUG

Etodolac-lidocaine topical patch

Once daily

DRUG

Placebo

Once daily

Trial Locations (1)

91195

Lotus Clinical Research, Pasadena

All Listed Sponsors
lead

MEDRx USA, Inc.

INDUSTRY

NCT02695381 - Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness | Biotech Hunter | Biotech Hunter